ArticleJournal of neurology2026

From measurement to biomarker trajectories: platform-agnostic Z score analysis of serum NfL and GFAP in ocrelizumab-treated multiple sclerosis.

Hernan Inojosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.